Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands.

Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koopmans MP, Frankena K, de Roda Husman AM, De Jong MC, Van Der Poel WH.

Epidemiol Infect. 2008 Apr;136(4):567-76. Epub 2007 Jun 20.

2.

Hepatitis E is a cause of unexplained hepatitis in The Netherlands.

Waar K, Herremans MM, Vennema H, Koopmans MP, Benne CA.

J Clin Virol. 2005 Jun;33(2):145-9. Epub 2004 Dec 8.

PMID:
15911430
3.

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation.

Storek J, Dawson MA, Lim LC, Burman BE, Stevens-Ayers T, Viganego F, Herremans MM, Flowers ME, Witherspoon RP, Maloney DG, Boeckh M.

Bone Marrow Transplant. 2004 Feb;33(3):337-46.

PMID:
14647254
4.

Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.

Storek J, Viganego F, Dawson MA, Herremans MM, Boeckh M, Flowers ME, Storer B, Bensinger WI, Witherspoon RP, Maloney DG.

Blood. 2003 Apr 15;101(8):3319-24. Epub 2002 Dec 27.

5.

Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.

Herremans MM, Reimerink JH, Ras A, Van Der Avoort HG, Kimman TG, Van Loon AM, Conyn-Van Spaendonck MA, Koopmans MP.

Clin Diagn Lab Immunol. 1997 Nov;4(6):659-64.

6.

Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.

Herremans MM, van Loon AM, Reimerink JH, Rümke HC, van der Avoort HG, Kimman TG, Koopmans MP.

Clin Diagn Lab Immunol. 1997 Sep;4(5):499-503.

Supplemental Content

Loading ...
Support Center